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Abstract
Background: Dengue is a major health problem in tropical areas, including Taiwan. Dengue virus infection affects
various types of cells and results in elevation of serum inflammatory molecules. Because these molecules may be
associated with dengue virus infection, the aim of this study was to identify novel molecules in febrile patients with
dengue infection. In addition, we determined whether these molecules were correlated with the count of
leukocytes and platelets.
Methods: Febrile adults (Age >18 years old) who presented to the emergency department and were confirmed
dengue virus infection were enrolled in this study. Serum from dengue patients and healthy controls was collected
and serum level of sepsis-associated inflammatory molecules was measured by Luminex assay.
Results: Elevated level of macrophage migration inhibitory factor, soluble vascular cell adhesion molecule-1, sFasL,
resistin and interferon-γ were detected in patients’ serum. Higher levels of neutrophil gelatinase-associated lipocalin
(NGAL) and resistin were detected in dengue patients with normal leukocyte count and all dengue patients,
respectively. Furthermore, the serum level of NGAL, but not resistin, was correlated with cell count in dengue
patients.
Conclusion: Our results revealed that resistin and NGAL are novel dengue-associated molecules. These results may
help elucidate the regulatory mechanisms of anti-dengue immune responses.
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Background
Dengue is a mosquito-borne viral disease caused by
four serotypes of dengue virus and is endemic in
tropical and subtropical areas including Southeast
Asia [1]. A report from World Health Organization
indicated the incidence of dengue fever has risen 30-
fold in the past 50 years [2]. A recent study revealed
that 390 million people were estimated to be infected
with dengue per year [3]. According to the Taiwan
National Infectious Disease Statistics System, more
than 20,000 cases of dengue fever were diagnosed in
southern Taiwan, including Kaohsiung city and Tainan
city, since 2014 [4]. It is therefore a serious threat to
public health in Taiwan and tropical countries.
Infection with any dengue serotype causes a wide
spectrum of symptoms, ranging from a mild flu-like syn-
drome (dengue fever) to a severe syndrome (dengue
hemorrhagic fever and dengue shock syndrome) [2]. On-
set of fever is observed in dengue patients during the
acute febrile phase of dengue. The acute phase of illness
lasts for 3–7 days, and then the convalescent phase lasts
for several days to several weeks [5, 6]. Because dengue
virus infects various cell types, including peripheral leu-
kocytes and endothelial cells [7], the levels of multiple
cytokines and chemokines such as macrophage migra-
tion inhibitory factor (MIF), tumor necrosis factor alpha
(TNF-α), interleukin (IL)-1β, and interferon-γ (IFN-γ),
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increase at different time points during the disease
course [8–10]. The serum level of neutrophils-secreted
elastase in patients with dengue shock syndrome is
higher than in dengue patients without shock [11, 12].
In addition, dengue virus-infected patients have elevated
levels of soluble intercellular cell adhesion molecule 1
(sICAM-1) and soluble vascular adhesion molecule-1
(sVCAM-1), which may regulate the activation and dam-
age of endothelial cells [13]. Fas/Fas ligand (FasL) path-
ways participate in dengue virus-induced apoptosis of
endothelial cells [14]. On the other hand, low platelet
count and low leukocyte count are often observed in
dengue patients [15, 16]. Platelets-secreted molecules
may play a role in both dengue pathogenesis and inflam-
mation regulation because dengue virus also alters
platelets-leukocytes and platelets-endothelial cells inter-
actions [17]. Activated platelets affect the production of
IL-10 and TNF-α from mononuclear cells [18]. Because
some of the aforementioned molecules were common
markers in both sepsis and dengue [19], we were inter-
ested in whether other sepsis-associated molecules were
also associated with dengue infection.
This study aimed to determine novel dengue-associated
molecules in febrile patients. The Luminex assays were
used for analyzing the sepsis-associated molecules in
serum of dengue patients and healthy controls. In order to
determine the potential association between these mole-
cules and cell types (such as leukocytes and endothelial
cells), the expression pattern of serum molecules in online
available dataset was analyzed, either. Because low white
blood cell count and low platelet count are clinical fea-
tures of dengue, we also investigated whether the concen-
tration of these molecules were correlated with white
blood cell count and platelet count.
Methods
Sample collection
Adult patients (age >18 years old) who presented to the
emergency department of Kaohsiung Medical University
Hospital with fever (tympanic temperature >38.3 °C)
from Sep 2014 to Dec 2014 were eligible for the study.
After obtaining informed consent, 10 ml of blood was
drawn and then the serum separated and stored in ali-
quots in −80 °C. Because dengue is a notifiable disease
in Taiwan, serum should be collected from all patients
with suspected dengue infection and sent to the Taiwan
Centers for Disease Control (CDC), where final confirm-
ation of the diagnosis was made (The commercial DENV
Ag NS1 Strip [Bio-Rad] was used). Patients with dengue
confirmed by CDC were selected and their sera were
used for the following Luminex assay. The sera from
healthy controls were also collected after obtaining
informed consent.
Quantification of sepsis-associated molecules
The concentration of serum molecules was determined
by using Luminex technology. MILLIPLEX MAP Hu-
man Sepsis Magnetic Bead Panel 1 (macrophage migra-
tion inhibitory factor [MIF], soluble intercellular
adhesion molecule 1 [sICAM-1], soluble Fas [sFas], sol-
uble Fas ligand [sFasL], soluble vascular cell adhesion
molecule 1 [sVCAM-1], and total plasminogen activator
inhibitor-I [tPAI-I]) (Millipore, Billerica, MA, USA),
MILLIPLEX MAP Human Sepsis Magnetic Bead Panel 3
(lactoferrin, elastase 2, neutrophil gelatinase–associated
lipocalin [NGAL], resistin, and thrombospondin-1)
(Millipore, Billerica, MA, USA) and Magnetic Luminex
Performance Assay (Human High Sensitivity Cytokine
Base Kit A, interferon-γ [IFN-γ]) (R&D Systems, Minne-
apolis, MN, USA) were used for determining the serum
levels of these molecules according to the manufacturer’s
instructions. Data was acquired on Luminex xMAP
technology (Millipore, St Charles, MO, US). For concen-
tration calculation, the calibration curve for each serum
molecule was analyzed with a five parameter logistic
curve fit curve through the Milliplex Analyst Software
(Viagene Tech, Carlisle, MA, USA).
Collection of independent microarrays dataset regarding
dengue virus infection
The publicly available microarray dataset was obtained
from NCBI Gene Expression Omnibus datasets (GEO
dataset, http://www.ncbi.nlm.nih.gov/gds/) [20]. Briefly,
we searched “dengue” at GEO datasets and then the re-
sults were filtered by the criteria “human” and “expres-
sion profiling by array.” After excluding the datasets
from cell lines and peripheral blood mononuclear cells
(PBMC) and datasets without healthy control, the data-
set with GEO Series accession number of GSE51808
(http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=gse51808) was chosen. The dataset contains
healthy controls (9 healthy controls) and dengue patients
(18 dengue fever patients and 10 dengue hemorrhagic
fever patients) [21]. Expression values were adapted
from GEO2R.
Statistical analysis
Differences between two independent groups were ana-
lyzed with student’s T test (Two tailed). Comparisons
between three groups were done with one-way ANOVA
test, followed by Bonferroni’s multiple comparison test.
The results were expressed as the median and the inter
quartile range. Correlation was estimated with Spear-
man’s correlation. Graphs and statistical analysis were
carried out using GraphPad Prism version 5.03 (Graph-
Pad Software, San Diego, CA). P-value < 0.05 was con-
sidered significant.
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Results
Identification of dengue-associated molecules in serum of
dengue patients and healthy controls
Two hundred and seventy-four patients with non-severe
dengue (145 males, median age is 42.5), and 33 healthy
controls (20 males, median age is 37) were collected.
Serum levels of MIF, sVCAM-1, sFasL, resistin and IFN-
γ in dengue patients were significantly higher than those
in healthy controls (Table 1). To the best of our know-
ledge, this is the first report describing the association
between resistin and dengue infection. In order to com-
pare the expression pattern of these molecules in pa-
tients’ serum with the expression pattern of these
molecules in whole blood cells, we obtained microarray
data from Gene Expression Omnibus (GEO, accession
number: GSE51808, gene expression profile in whole
blood cells) [21]. As shown in Table 2, elevated mRNA
levels of MIF and decreased mRNA level of
thrombospondin-1 were observed in dengue patients
(including dengue fever and dengue hemorrhagic fever).
Different expression pattern was observed in serum of
dengue patients and RNA expression of whole blood
cells. In whole blood cells, there was no difference was
found in resistin level in dengue patients compared with
that in healthy control (Table 2).
Sepsis-associated molecules in patients with leukopenia
and thrombocytopenia
We further investigated whether the concentration of
these molecules were associated with blood cell counts in
dengue patients since leukopenia (<4000/mm3) and
thrombocytopenia (<100,000/mm3) are common clinical
features of dengue. The levels of sVCAM-1 and IFN-γ
were significantly higher in both leukopenic and thrombo-
cytopenic dengue patients than in other dengue patients,
whereas the levels of elastase 2, lactoferrin, NGAL, and
thrombospondin-1 were significantly lower in both
leukopenic and thrombocytopenic dengue patients than
those in other dengue patients (Tables 3 and 4). The result
implies that NGAL is a novel molecule which might asso-
ciate with anti-dengue immune responses. Similar expres-
sion pattern of these molecules was observed in the
leukopenic group and thrombocytopenic group. The re-
sults might suggest the level of elastase 2, lactoferrin,
NGAL, and thrombospondin-1 associate with the number
of leukocytes and platelets.
Correlation between those molecules with leukocyte and
platelet count in dengue patients
Increased serum level of resistin was observed in dengue
patients. Serum NGAL level was significantly higher in
dengue patients without leukopenia or thrombocytopenia
than those with leukopenia or thrombocytopenia (Fig. 1).
In contrast, serum resistin level was similar in the groups
of dengue patients classified by the presence of leukopenia
or thrombocytopenia (Fig. 1). The results further suggest
the NGAL level correlates with the number of blood cells.
Further analyses showed that serum level of NGAL, but
not resistin, was correlated with leukocyte and platelet
count in dengue patients (Table 5). Elastase 2 and lactofer-
rin were correlated with leukocyte and platelet count,
either.
Discussion
In 2014, there was a dengue fever outbreak in Taiwan and
96 % of patients were from Kaohsiung city [22]. A recent
report indicates dengue virus 1 is dominant serotype [23].
Because patients were enrolled from Sep 2014 to Dec
2014 in Kaohsiung city, we supposed serotype I was pre-
dominant serotype in our study. Furthermore, a report
indicated around 70 % of non-dengue virus 2 infection
(dengue virus 1 and dengue virus 3) is primary infection
Table 1 Serum concentrations of sepsis-associated molecules in healthy donors and dengue patients
Healthy controls (n = 33) Dengue patients (n = 274) P value
MIF 190.1 ± 27.83 753.6 ± 27.83 0.0046
sICAM-1 151,276 ± 12,035 381,200 ± 44,284 0.0776
sVCAM-1 487,114 ± 27,041 1,681,017 ± 30,861 <0.0001
sFasL 32.04 ± 1.657 76.04 ± 2.224 <0.0001
sFas 5428 ± 2622 5205 ± 325 0.8639
tPAI-1 117,506 ± 6263 122,256 ± 2207 0.4803
Elastase 2 76,746 ± 9427 73,292 ± 3601 0.7511
Lactoferrin 199,422 ± 22,270 244,062 ± 12,547 0.2263
NGAL 183,962 ± 16,769 272,870 ± 18,830 0.1047
Resistin 8778 ± 1099 17,451 ± 707.6 <0.0001
Thrombospondin-1 9,873,050 ± 214,185 9,749,456 ± 695,838 0.8513
IFN-γ 0.182 ± 0.003 5.377 ± 1.147 <0.0001
Note: Serum concentrations (pg/mL) of molecules were expressed in Mean ± SEM
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in Taiwan [24]. It might imply that enrolled patients with
primary infection were dominant. Our results showed the
serum concentrations of MIF, sVCAM-1, sFasL, resistin,
and IFN-γ were significantly higher in dengue patients
than that in healthy controls. Previous studies have indi-
cated that elevated serum levels of MIF, sVCAM-1, sFas,
sFasL, and IFN-γ are associated with dengue [9, 10, 13,
14]. Similar expression pattern was observed in the
present study. To the best of our knowledge, this is the
first report describing elevated serum levels of resistin in
dengue patients.
Previous studies have shown that elastase 2, lactoferrin,
and NGAL are mainly secreted from neutrophils [25].
Elastase 2 and lactoferrin locate in azurophilic granules
and specific granules, respectively [26]. Increasing serum
levels of elastase 2 and lactoferrin are correlated with
neutrophil degranulation and IL-8 is one of the important
regulators for neutrophil degranulation in dengue-infected
children [11, 27]. NGAL is a kind of protein inhibiting
bacterial growth [28]. The role of NGAL is unclear in den-
gue infection. The plasma and urine NGAL level in
rotavirus-induced dehydration is higher than that in
healthy controls [29]. However, the function of NGAL is
not well-known in dengue infection. In addition, NGAL is
a biomarker for human acute kidney injury [30]. Although
dengue hemorrhagic fever is reported to be a risk factor of
acute kidney factor in children [31], the NGAL level does
not reveal significant difference between dengue patients
and healthy controls in adults. In this study, the dengue
patients were enrolled after fever onset. We assumed that
most of enrolled patients might be in the acute febrile
phase and critical phase of dengue. Relatively low level of
Table 2 Gene expression between health donors and dengue patients (adapted from GEO dataset: GSE51808)
Gene symbol Probe Healthy (n = 9) Dengue (n = 28) P value
MIF 217871_PM_s_at 10.28 ± 0.05 11.29 ± 0.12 <0.0001
ICAM-1 202637_PM_s_at 7.34 ± 0.12 7.84 ± 0.16 0.0987
VCAM-1 203868_PM_s_at 3.39 ± 0.07 3.29 ± 0.08 0.4704
FasL 210865_PM_at 6.34 ± 0.30 6.07 ± 0.16 0.4339
Fas 216252_PM_x_at 8.51 ± 0.14 7.85 ± 0.19 0.0669
PAI-1 1568765_PM_at 4.92 ± 0.17 4.88 ± 0.09 0.6271
Elastase 2 206871_PM_at 4.65 ± 0.27 4.80 ± 0.30 0.7888
Lactoferrin 202018_PM_s_at 8.50 ± 0.42 9.43 ± 0.35 0.1748
NGAL 212531_PM_at 8.15 ± 0.18 8.76 ± 0.19 0.0975
Resistin 220570_PM_at 6.63 ± 0.38 7.01 ± 0.25 0.4565
Thrombospondin-1 215775_PM_at 3.90 ± 0.07 3.74 ± 0.05 0.0272
IFN-γ 210354_PM_at 5.80 ± 0.23 6.29 ± 0.16 0.1333
Note
The number in parentheses is the number of patients
The Dengue group includes patients with dengue fever (n = 18) and dengue hemorrhagic fever (n = 10)
Expression values of molecules were expressed in Mean ± SEM
Table 3 Serum concentrations of sepsis-associated molecules in dengue patients with different leukocyte counts
Leukocyte count <4000/mm3 (n = 158) Leukocyte count >4000/mm3 (n = 116) P value
MIF 741.5 ± 86.56 770.1 ± 106.9 0.8338
sICAM-1 390,856 ± 63,423 368,049 ± 59,280 0.7996
sVCAM-1 1,861,371 ± 46,636 1,435,361 ± 34,827 <0.0001
sFasL 75.38 ± 2.79 76.94 ± 3.63 0.7295
sFas 5744 ± 502.9 4471 ± 337.5 0.0526
tPAI-1 120,103 ± 2986 125,189 ± 3258 0.2557
Elastase 2 60,422 ± 3308 90,821 ± 6909 <0.0001
Lactoferrin 200,423 ± 20,354 303,259 ± 21,099 <0.0001
NGAL 221,109 ± 8826 343,372 ± 42,051 0.0012
Resistin 17,016 ± 835 17,920 ± 1227 0.5706
Thrombospondin-1 8,699,875 ± 256,414 11,230,123 ± 321,044 <0.0001
IFN-γ 7.696 ± 1.91 2.219 ± 0.64 0.0180
Note: Serum concentrations (pg/mL) of molecules were expressed in Mean ± SEM
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Table 4 Serum concentrations of sepsis-associated molecules in dengue patients with different platelet counts
Platelet count <100,000/mm3 (n = 83) Platelet count >100,000/mm3 (n = 191) P value
MIF 816.7 ± 133.5 726.1 ± 77.27 0.5370
sICAM-1 463,596 ± 114,059 345,395 ± 39,751 0.2206
sVCAM-1 1,920,550 ± 45,670 1,576,926 ± 37,198 <0.0001
sFasL 73.75 ± 3.96 77.04 ± 2.76 0.4976
sFas 6274 ± 879 4741 ± 262 0.0299
tPAI-1 118,768 ± 4450 123,770 ± 2508 0.2984
Elastase 2 54,986 ± 4241 81,246 ± 4718 0.0007
Lactoferrin 173,218 ± 18,650 274,264 ± 15,551 0.0002
NGAL 206,081 ± 10,558 301,894 ± 26,368 0.0191
Resistin 18,640 ± 1213 16,934 ± 866 0.2687
Thrombospondin-1 7,557,301 ± 357,474 10,722,449 ± 232,877 <0.0001
IFN-γ 10.23 ± 3.45 3.26 ± 0.63 0.0051
Note: Serum concentrations (pg/mL) of molecules were expressed in Mean ± SEM
Fig. 1 The levels of NGAL and resistin in healthy controls and dengue patients with different cell count. Bar graphs showing the serum
concentration of (a) NGAL and (b) resistin in healthy controls and dengue patients with different leukocyte count; (c) NGAL and (d) resistin in
healthy controls and dengue patients with different platelet count. All quantitative data are expressed as means ± SD. * p < 0.05; *** p < 0.0001
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all three molecules was observed in dengue patients with
leukopenia and thrombocytopenia (Tables 3 and 4). All
molecules were significantly correlated with leukocyte and
platelet count (Table 5). The highest virus titer is in the fe-
brile phase of dengue (1–3 days post fever onset) and the
number of leukocyte and platelet decreases is in critical
phase (4–6 days post fever onset) [32]. It might suggest
elastase 2, lactoferrin and NGAL play a role in anti-
dengue immune responses in febrile phase.
Potts and colleagues report that dengue patients had
lower platelet, white blood cell and neutrophil counts
[33]. Although we did not count neutrophils in this study,
we supposed serum levels of elastase 2, lactoferrin, and
NGAL correlated with neutrophil counts in adult dengue
patients. A recent study indicated that the concentration
of the endothelial cell-related molecule VCAM-1 was
negatively correlated with neutrophil count [34]. In Ta-
bles 3 and 4, the level of sVCAM-1, IFN-γ and three
neutrophils-related molecules showed opposite expression
pattern in the leukopenic group and thrombocytopenic
group. Thrombospondin-1 which is an inflammatory mol-
ecule in activated platelet shows similar expression pattern
with elastase 2, lactoferrin, and NGAL in this study [35].
It needs to further investigate whether these molecules in-
volve in the regulation of the interaction between T cells,
neutrophils, platelet, and endothelial cells during dengue
infection in the future.
Resistin is a kind of adipokine and is involved in vari-
ous inflammatory processes [36, 37]. Peripheral blood
mononuclear cells (PBMCs), macrophages, and bone
marrow cells are major sources of resistin in human
[38]. Circulating levels of IL-6, IL-10 and IFN-
γ associated with the level of resistin in an obese mouse
model [39]. Pro-inflammatory cytokines, such as IL-6
and TNF-α induce mRNA expression of resistin in hu-
man PBMCs. Resistin is significantly correlated with IL-
6 and ICAM-1 in patients with obstructive sleep apnea
syndrome [40]. The present study showed that serum
resistin level significantly increased in dengue patients.
Our results indicated that resistin did not correlate with
leukocyte and platelet count although human PBMC
and macrophage are reported to secret resistin [38]. Per-
sistent human papillomavirus infection increases the
resistin level in plasma of older women [41]. However,
the function of resistin in dengue virus and human pap-
illomavirus infection is still unknown. In addition, we
observed high expression level of resistin, MIF and sFasL
in dengue patients and no significant correlation be-
tween these molecules and leukocyte and platelet count.
It suggests that serum resistin and sFasL might be po-
tential biomarkers for dengue infection since MIF is cor-
related with disease severity and clinical outcome in
dengue [10].
Conclusion
We demonstrated that five inflammatory molecules were
elevated in the serum from dengue patients. NGAL and
resistin were novel dengue-associated molecules while
NGAL might associate with anti-dengue immune
responses and resistin might be a novel biomarker for
dengue infection. Further investigation to determine
their roles in dengue infection may contribute to the un-
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